(3β)-18,19-Didehydro-10-methoxy-16-[(R)-2,3,4,9-tetrahydro-6-methoxy-1H-pyrido[3,4-b]indol-1-yl]-17-norcorynan

(3β)-18,19-Didehydro-10-methoxy-16-[(R)-2,3,4,9-tetrahydro-6-methoxy-1H-pyrido[3,4-b]indol-1-yl]-17-norcorynan Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

The empirical formula of cinchophyllamine should read C31H36N204. The specific rotation has been reported as [α]_D³⁰ + 23° (c 0.4, CHCI3).

Einzelnachweise

LeMen et al., Ann. Pharm. Fr., 23,691 (1965)

(3β)-18,19-Didehydro-10-methoxy-16-[(R)-2,3,4,9-tetrahydro-6-methoxy-1H-pyrido[3,4-b]indol-1-yl]-17-norcorynan Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(3β)-18,19-Didehydro-10-methoxy-16-[(R)-2,3,4,9-tetrahydro-6-methoxy-1H-pyrido[3,4-b]indol-1-yl]-17-norcorynan Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate

---

• (3β)-18,19-Didehydro-10-methoxy-16-[(R)-2,3,4,9-tetrahydro-6-methoxy-1H-pyrido[3,4-b]indol-1-yl]-17-norcorynan
• Cinchophyllamine
• Indolo[2,3-a]quinolizine, 3-ethenyl-1,2,3,4,6,7,12,12b-octahydro-9-methoxy-2-[[(1R)-2,3,4,9-tetrahydro-6-methoxy-1H-pyrido[3,4-b]indol-1-yl]methyl]-, (2R,3R,12bR)- (9CI)
• 10438-16-1